Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)Study completedNCT01727089
What this trial is testing

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT00401128
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
The Cleveland Clinic 9
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00035243
What this trial is testing

EPO906 Therapy in Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)Study completedNCT02127710
What this trial is testing

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Who this might be right for
Papillary Renal Cell Cancer
AstraZeneca 111
Testing effectiveness (Phase 2)Study completedNCT01502410
What this trial is testing

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

Who this might be right for
Childhood Hepatocellular CarcinomaPapillary Thyroid CancerPreviously Treated Childhood Rhabdomyosarcoma+4 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT02019693
What this trial is testing

The MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00726323
What this trial is testing

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 74
Testing effectiveness (Phase 2)Looking for participantsNCT04981509
What this trial is testing

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Who this might be right for
Hereditary Leiomyomatosis and Renal Cell CarcinomaPapillary Renal Cell CarcinomaRenal Cell Carcinoma+3 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT00276614
What this trial is testing

Bortezomib in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081
What this trial is testing

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

Who this might be right for
Metastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

Who this might be right for
Advanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more
National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Study completedNCT02819596
What this trial is testing

MEDI4736 Combinations in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Clear Cell CarcinomaRenal Papillary Cell Carcinoma
Queen Mary University of London 69
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)UnknownNCT05096390
What this trial is testing

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Who this might be right for
Papillary Renal Cell Carcinoma Type 2
Centre Leon Berard 72
Not applicableStudy completedNCT06339138
What this trial is testing

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Papillary Renal TumorClear Cell Renal Cell Carcinoma+3 more
Mayo Clinic 589
Early research (Phase 1)Study completedNCT01198184
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Who this might be right for
Endometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaRecurrent Renal Cell Cancer+5 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT01100619
What this trial is testing

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerHuerthle Cell Thyroid Cancer+1 more
Exelixis 40
Next Page